MOH INVESTOR NOTICE: Faruqi & Faruqi, LLP Announces that Molina Healthcare Investors Have Opportunity to Lead Class Action Lawsuit

Core Viewpoint - Molina Healthcare, Inc. is facing a potential class action lawsuit due to allegations of misleading statements regarding its financial health and medical cost trends, with a deadline for investors to seek lead plaintiff status by December 2, 2025 [2][5]. Summary by Sections Legal Action - Faruqi & Faruqi, LLP is investigating claims against Molina Healthcare and encourages affected investors to contact them for legal options [1][2]. - The firm has a history of recovering significant amounts for investors since its establishment in 1995 [4]. Allegations Against Molina - The complaint alleges that Molina and its executives violated federal securities laws by making false or misleading statements and failing to disclose critical information regarding: 1. Medical cost trend assumptions [5]. 2. Dislocation between premium rates and medical costs [5]. 3. Dependency on low utilization of various health services for near-term growth [5]. 4. Likelihood of substantial cuts to financial guidance for fiscal year 2025 [5]. 5. Misleading positive statements about the company's business and prospects [5]. Financial Performance and Stock Impact - On July 7, 2025, Molina announced second-quarter results, revealing adjusted earnings of approximately $5.50 per share, which was below expectations due to medical cost pressures [6][8]. - The company cut its full-year adjusted earnings guidance by 10.2%, from at least $24.50 per share to a range of $21.50 to $22.50 per share [8]. - Following this announcement, Molina's stock price fell by $6.97, or 2.9%, closing at $232.61 per share on July 7, 2025 [8]. - On July 23, 2025, Molina further reduced its full-year earnings guidance, reporting a GAAP net income of $4.75 per diluted share for the second quarter, an 8% decrease year-over-year [9]. - The new guidance indicated a 13.6% cut to earnings per share, with full-year GAAP net income guidance reduced by 27% to $912 million [9]. - This led to a significant stock price drop of $32.03, or 16.84%, closing at $158.22 per share on July 24, 2025 [9].